• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生理盐水灌洗治疗严重脓胸:一项队列研究。

Saline lavage for the management of severe pleural empyema: A cohort study.

机构信息

Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Marseille, France.

Aix-Marseille University, Marseille, France.

出版信息

Clin Respir J. 2021 Oct;15(10):1097-1103. doi: 10.1111/crj.13415. Epub 2021 Aug 11.

DOI:10.1111/crj.13415
PMID:34216522
Abstract

BACKGROUND

Despite advances in the treatment of pleural infection, up to 20% of patients die. So far, studies assessing the role of intrapleural saline lavage for the management of all stage pleural infections are very scarce, usually excluding patients with cancer.

METHODS

The method used was a retrospective cohort study including pleural empyema managed with a pleural lavage of saline solution through a small-bore chest tube. The primary outcome was the rate of failure at 3 months (surgical referral or additional pleural manoeuver due to recurrent infection or all-cause mortality). Secondary outcomes were hospital stay, the change of the chest radiograph and inflammatory biomarkers, and complications.

RESULTS

Thirty patients with pleural empyema were included, 11 (36.7%) with an active cancer. The overall rate of failure at 3 months was 13.3% (surgical referral = 0; additional pleural manoeuver = 3; mortality = 1). Median length of pleural lavage and hospital stay were, respectively, 14 days (7-28) and 17 days (11-42). Inflammatory markers and size of the effusion on chest radiograph significantly decreased for Day 0 to Day 14. No chest tube blockade was reported, but seven (23.3%) accidentally withdrew. No other side effects were reported.

CONCLUSIONS

Intrapleural saline lavage is efficient and safe for the management of pleural empyema, even in severe status patients with cancer, at the cost of a prolonged hospitalization.

摘要

背景

尽管在胸膜感染的治疗方面取得了进展,但仍有 20%的患者死亡。迄今为止,评估胸腔内生理盐水灌洗在所有阶段胸膜感染治疗中作用的研究非常稀缺,通常排除癌症患者。

方法

该方法采用回顾性队列研究,包括通过小口径胸腔管进行盐水胸膜灌洗来治疗脓胸。主要结局是 3 个月时的失败率(因再次感染或全因死亡率而转诊手术或再次进行胸膜操作)。次要结局是住院时间、胸部 X 线片和炎症生物标志物的变化以及并发症。

结果

共纳入 30 例脓胸患者,其中 11 例(36.7%)患有活动性癌症。3 个月时的总失败率为 13.3%(转诊手术=0;再次进行胸膜操作=3;死亡=1)。胸膜灌洗和住院的中位时间分别为 14 天(7-28)和 17 天(11-42)。炎症标志物和胸部 X 线片中胸腔积液的大小在第 0 天至第 14 天显著下降。未报告胸腔引流管堵塞,但有 7 例(23.3%)意外拔出。未报告其他副作用。

结论

即使在癌症严重的患者中,胸腔内生理盐水灌洗在治疗脓胸方面也是有效且安全的,但会延长住院时间。

相似文献

1
Saline lavage for the management of severe pleural empyema: A cohort study.生理盐水灌洗治疗严重脓胸:一项队列研究。
Clin Respir J. 2021 Oct;15(10):1097-1103. doi: 10.1111/crj.13415. Epub 2021 Aug 11.
2
Complications of cerebral air embolism associated with pleural lavage for empyema.胸腔灌洗治疗脓胸并发脑空气栓塞并发症。
BMJ Case Rep. 2022 Jun 27;15(6):e249618. doi: 10.1136/bcr-2022-249618.
3
Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.与盐水冲洗相比,胸膜腔内注射阿替普酶可更大程度地减少儿童肺炎旁胸腔积液量。
Pediatr Pulmonol. 2015 Dec;50(12):1328-35. doi: 10.1002/ppul.23184. Epub 2015 Apr 2.
4
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与安慰剂或不同的纤维蛋白溶解剂在治疗成人肺炎旁胸腔积液和脓胸中的比较。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
5
Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.胸腔内组织型纤溶酶原激活剂和脱氧核糖核酸酶α联合治疗与单独使用组织型纤溶酶原激活剂治疗儿童脓胸的疗效:一项随机临床试验。
JAMA Pediatr. 2020 Apr 1;174(4):332-340. doi: 10.1001/jamapediatrics.2019.5863.
6
Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.胸腔内纤维蛋白溶解治疗与早期内科胸腔镜治疗胸腔感染。随机对照临床试验。
Ann Am Thorac Soc. 2020 Aug;17(8):958-964. doi: 10.1513/AnnalsATS.202001-076OC.
7
The clinician's perspective on parapneumonic effusions and empyema.临床医生对肺炎旁胸腔积液和脓胸的看法。
Chest. 1993 Jan;103(1):259-61. doi: 10.1378/chest.103.1.259.
8
Medical management of parapneumonic pleural disease.肺炎旁胸腔疾病的药物治疗
Pediatr Pulmonol. 2005 Feb;39(2):127-34. doi: 10.1002/ppul.20127.
9
Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score.应用 RAPID 评分对复杂性类肺炎旁胸腔积液和脓胸患者进行风险分层。
Lung. 2018 Oct;196(5):623-629. doi: 10.1007/s00408-018-0146-2. Epub 2018 Aug 11.
10
New trends in the diagnosis and treatment in parapneumonic effusion and empyema.肺炎旁胸腔积液和脓胸诊断与治疗的新趋势
Tuberk Toraks. 2008;56(1):113-20.

引用本文的文献

1
Effective Treatment of Empyema With Fistula Using Saline Irrigation Through Tube Thoracostomy: A Case Report.经胸腔闭式引流管生理盐水冲洗治疗合并瘘管的脓胸:1例报告
Cureus. 2025 Jun 19;17(6):e86386. doi: 10.7759/cureus.86386. eCollection 2025 Jun.
2
A potential prospect: The novel treatment of intrapleural saline irrigation with intrapleural tyloxapol in treating thoracic empyema.一种潜在的前景:胸腔内用泰洛沙泊盐水冲洗治疗脓胸的新方法。
Respirol Case Rep. 2024 Aug 10;12(8):e70000. doi: 10.1002/rcr2.70000. eCollection 2024 Aug.
3
Infective Pleural Effusions-A Comprehensive Narrative Review Article.
感染性胸腔积液——一篇综合性叙述性综述文章
Clin Pract. 2024 May 16;14(3):870-881. doi: 10.3390/clinpract14030068.
4
Pleural Space Infections.胸腔感染
Life (Basel). 2023 Jan 29;13(2):376. doi: 10.3390/life13020376.
5
Medical management of pleural infection: Why not saline intrapleural lavage?胸膜感染的医学管理:为何不采用胸腔内盐水灌洗?
Clin Respir J. 2022 Nov;16(11):693-695. doi: 10.1111/crj.13548. Epub 2022 Sep 29.
6
Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study.胸腔感染中联合应用胸腔内纤维蛋白溶解酶和酶治疗的出血风险:一项国际性、多中心、回顾性队列研究。
Chest. 2022 Dec;162(6):1384-1392. doi: 10.1016/j.chest.2022.06.008. Epub 2022 Jun 16.